MedPath

Skin Cancer Screening and Education at Beaches

Not Applicable
Completed
Conditions
Skin Cancer
Registration Number
NCT00894855
Lead Sponsor
Dana-Farber Cancer Institute
Brief Summary

This study was an evaluation of the Dana-Farber Cancer Institute Blum Family Resource Center Van's existing skin cancer screening and education program. This program occurred over 2 summers. This study will fill a critical gap in the investigators' knowledge about how best to address the high-risk behaviors that regularly occur during the summertime at beaches. The investigators randomized beaches to receive different combinations of the van program components in order to determine how services should optimally be configured to maximize impact. The investigators hypothesized that providing all three components (1-Skin cancer prevention education; 2-Biometric feedback using a Dermascan Analyzer that illustrates skin damage due to sun exposure and Ultra Violet (UV) Reflectance Photography; and 3-Dermatologist skin exam) will maximize knowledge and behavior change, relative to education alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
634
Inclusion Criteria
  • Beachgoers eligible to participate in the study included:

    • those who were 18 years and older
    • Caucasian
    • able to understand, speak and read English
    • ability to give informed consent
    • had not already enrolled in the study at another participating beach
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
sun protection behaviors4-6 months post-intervention
skin self-exams4-6 months post-intervention
sun burns4-6 months post-intervention
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dana-Farber Cancer Institute

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Dana-Farber Cancer Institute
πŸ‡ΊπŸ‡ΈBoston, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.